← Back to headlines
Cytosorbents Projects Cash Flow Breakeven by Second Half of 2026
Cytosorbents has outlined its strategy to achieve cash flow breakeven by the second half of 2026, attributing this positive outlook to continued growth in its international sales.
25 Mar, 22:46 — 25 Mar, 22:46
Sources
Showing 1 of 1 sources
